Closed-loop optimization of chromatography column sizing strategies in biopharmaceutical manufacture

被引:17
作者
Allmendinger, Richard [1 ]
Simaria, Ana S. [1 ]
Turner, Richard [2 ]
Farid, Suzanne S. [1 ]
机构
[1] UCL, Dept Biochem Engn, Adv Ctr Biochem Engn, London WC1E 7JE, England
[2] MedImmune Ltd, Cambridge CB1 6GH, England
基金
英国工程与自然科学研究理事会;
关键词
biopharmaceutical manufacture; antibody purification technologies; downstream processing design; evolutionary computation; closed-loop optimization; process economics; ANTIBODY PURIFICATION; MASS-SPECTROMETRY; DESIGN; ALGORITHM; DISCOVERY; OPERATION; FRAMEWORK;
D O I
10.1002/jctb.4267
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BACKGROUNDThis paper considers a real-world optimization problem involving the identification of cost-effective equipment sizing strategies for the sequence of chromatography steps employed to purify biopharmaceuticals. Tackling this problem requires solving a combinatorial optimization problem subject to multiple constraints, uncertain parameters, and time-consuming fitness evaluations. RESULTSAn industrially-relevant case study is used to illustrate that evolutionary algorithms can identify chromatography sizing strategies with significant improvements in performance criteria related to process cost, time and product waste over the base case. The results demonstrate also that evolutionary algorithms perform best when infeasible solutions are repaired intelligently, the population size is set appropriately, and elitism is combined with a low number of Monte Carlo trials (needed to account for uncertainty). Adopting this setup turns out to be more important for scenarios where less time is available for the purification process. Finally, a data-visualization tool is employed to illustrate how user preferences can be accounted for when it comes to selecting a sizing strategy to be implemented in a real industrial setting. CONCLUSIONThis work demonstrates that closed-loop evolutionary optimization, when tuned properly and combined with a detailed manufacturing cost model, acts as a powerful decisional tool for the identification of cost-effective purification strategies. (c) 2013 The Authors. Journal of Chemical Technology & Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
引用
收藏
页码:1481 / 1490
页数:10
相关论文
共 30 条
[1]  
Allmendinger R., 2012, Ph.D. dissertation
[2]  
BOX GEP, 1957, ROY STAT SOC C-APP, V6, P81
[3]   Automated Discovery of Novel Drug Formulations Using Predictive Iterated High Throughput Experimentation [J].
Caschera, Filippo ;
Gazzola, Gianluca ;
Bedau, Mark A. ;
Moreno, Carolina Bosch ;
Buchanan, Andrew ;
Cawse, James ;
Packard, Norman ;
Hanczyc, Martin M. .
PLOS ONE, 2010, 5 (01)
[4]   Decision-support software for the industrial-scale chromatographic purification of antibodies [J].
Chhatre, Sunil ;
Thillaivinayagalingam, Pranavan ;
Francis, Richard ;
Titchener-Hooker, Nigel J. ;
Newcombe, Anthony R. ;
Keshavarz-Moore, Eli .
BIOTECHNOLOGY PROGRESS, 2007, 23 (04) :888-894
[5]  
Farid S.S., 2009, PROCESS SCALE PURIFI, P239
[6]   Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma [J].
Farid, Suzanne S. ;
Washbrook, John ;
Titchener-Hooker, Nigel J. .
COMPUTERS & CHEMICAL ENGINEERING, 2007, 31 (09) :1141-1158
[8]   Stochastic Combinatorial Optimization Approach to Biopharmaceutical Portfolio Management [J].
George, Edmund D. ;
Farid, Suzanne S. .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2008, 47 (22) :8762-8774
[9]   Strategic biopharmaceutical portfolio development: An analysis of constraint-induced implications [J].
George, Edmund D. ;
Farid, Suzanne S. .
BIOTECHNOLOGY PROGRESS, 2008, 24 (03) :698-713
[10]  
Hebbron T, 2008, ARTIF LIFE, VXI, P234